Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Zhongtai Bang Pharmaceutical Technology is a professional contract research organization (CRO) based in Beijing, China, specializing in the research and development of chemical drugs. Established in 2014, the company provides a full suite of services including chemical synthesis, formulation development, and quality control for both generic and innovative small molecule drugs. They operate out of the Daxing Bio-medicine Industry Base, offering technical transfer and regulatory filing support to pharmaceutical manufacturers. The firm is recognized for its expertise in high-end generic drug development and its ability to navigate the Chinese NMPA registration process. Their core business focuses on accelerating the path to market for domestic pharmaceutical companies through high-quality technical services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Zhongtai Bang Pharmaceutical Technology.